Mediastinal Tumor Clinical Trial
Official title:
A Prospective, Phase II Study of MR-Linac Guided Adaptive Radiotherapy for Inoperable Mediastinal Tumor
This Phase II study is to determine the efficacy and safety of MR-Linac Guided Radiotherapy in patients with inoperable mediastinal tumors.
This Phase II study is to determine the efficacy and safety of MR-Linac Guided Radiotherapy in patients with inoperable mediastinal tumors. Patients will receive radiotherapy on the MR-Linac treatment machine. The primary end point is 2-year local-recurrence free survival. The secondary end points are objective response rate, 2-y PFS, 2-y OS, safety of treatment, dose coverage of targets and dose to normal organs. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03613272 -
The Curative Effect of Extended Thymectomy Performed Through Subxiphoid-right VATS Approach With Elevation of Sternum
|
N/A | |
| Completed |
NCT03439696 -
Needlescopic-assisted Uniportal vs Uniportal VATS
|
N/A | |
| Not yet recruiting |
NCT03214341 -
Assessment of Mediastinal Masses With Diffusion Weighted MR Imaging
|
N/A | |
| Active, not recruiting |
NCT05267496 -
Oscillating Positive Expiratory Pressure Therapy for Patients With Thoracic Neoplasms Undergoing Chest Surgery
|
N/A | |
| Completed |
NCT03537430 -
Totally no Tube (TNT) Uniportal Video-assisted Thoracoscopic Surgery (VATS) VS Traditional Uniportal VATS for Mediastinal Tumor
|
N/A |